AptarGroup Inc (ATR) Actualités

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Aptar Reports Third Quarter 2024 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection...

Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection...

Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) authorized the repurchase of up to $500 million of the Company’s common stock. This new...

Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program

N-Sorb leverages company’s proven 3-Phase Activ-Polymer™ platform technology to address recent concerns...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities